Latest filing published 13 Dec 2022 for HTG Molecular Diagnostics, INC, €402.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Shaun D. McMeans: trading record in brief
Shaun D. McMeans is a declared insider of HTG Molecular Diagnostics, Inc (finance chief), with filings sourced from SEC (Form 4). The record holds 51 filings, for trades running from 11 May 2015 to 9 December 2022.
Both buying and selling appear: 1 purchase worth €4,368, against 9 sales worth €30k. The net balance comes to €25k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 32 share grants.
The newest entry dates from 13 December 2022: a share grant of €402, in HTG Molecular Diagnostics, Inc. The most recent open-market purchase was published on 12 August 2015, 4,106 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shaun D. McMeans
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$0.4258.9% of flowCommon StockSEC:0001209191-22-061007:0
- 29 shares@ US$1.030.6% of flowCommon StockSEC:0001209191-22-040340:0
- 1,000 shares@ US$0.4769.9% of flowCommon StockSEC:0001209191-22-036958:0
- 31 shares@ US$1.390.9% of flowCommon StockSEC:0001209191-22-022376:0
- 31 shares@ US$5.423.3% of flowCommon StockSEC:0001209191-22-000847:0
- 520 shares@ US$3.561536.3% of flowCommon StockSEC:0001209191-21-069772:0
- 31 shares@ US$5.713.4% of flowCommon StockSEC:0001209191-21-059009:0
- 31 shares@ US$5.813.4% of flowCommon StockSEC:0001209191-21-045184:0
- 469 shares@ US$3.918533.4% of flowCommon StockSEC:0001209191-21-040444:0
- 37 shares@ US$5.470.3% of flowCommon StockSEC:0001209191-21-024750:0
- 31 shares@ US$4.790.2% of flowCommon StockSEC:0001209191-21-000471:0
- 66 shares@ US$4.87054.3% of flowCommon StockSEC:0001209191-20-063872:0
- 461 shares@ US$0.332.1% of flowCommon StockSEC:0001209191-20-053294:0
- 447 shares@ US$0.724.2% of flowCommon StockSEC:0001209191-20-040517:0
- 1,000 shares@ US$0.55257.2% of flowCommon StockSEC:0001209191-20-036738:0
- 544 shares@ US$0.332.2% of flowCommon StockSEC:0001209191-20-022516:0
- 461 shares@ US$0.702.2% of flowCommon StockSEC:0001209191-20-000353:0
- 701 shares@ US$0.56562.7% of flowCommon StockSEC:0001209191-19-060257:0
- 461 shares@ US$0.662.1% of flowCommon StockSEC:0001209191-19-051702:0
- 461 shares@ US$1.665.1% of flowCommon StockSEC:0001209191-19-041086:0
- 761 shares@ US$1.577.4% of flowCommon StockSEC:0001209191-19-036611:0
- 447 shares@ US$2.507.0% of flowCommon StockSEC:0001209191-19-022089:0
- 461 shares@ US$2.547.2% of flowCommon StockSEC:0001209191-19-000595:0
- 735 shares@ US$1.577.1% of flowCommon StockSEC:0001209191-18-062947:0
- 461 shares@ US$4.528.7% of flowCommon StockSEC:0001209191-18-053326:0
25 of 50 declarations